AlphaYouME
Insider selling
Mark E. Bunnage sold $15K of Vertex Pharmaceuticals Inc / Ma (VRTX) stock
Mark E. Bunnage, EVP, Chief Scientific Officer of Vertex Pharmaceuticals Inc / Ma (VRTX), sold 33 shares of VRTX stock worth $15K, per an SEC Form 4 filed May 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 15, 2026, 4 days before it was made public.
VRTX has moved +16.9% since the trade date, from $436.95 to $510.72 (Sep 21, 2026 close).
- Traded
- May 15, 2026
- Disclosed
- May 19, 2026
- Filing delay
- 4 days
- Price since
- +16.9%
- Role
- EVP, Chief Scientific Officer
- Source
- SEC Form 4
More VRTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.